Search

everythinglearnresearchcommunity

for

Search:↓

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Metformin can cause hair loss in some women with PCOS.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Thai women with PCOS become more aware and change their lifestyle to manage their fertility and symptoms.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Women with PCOS may be more likely to have gum disease than healthy women.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

High BMI worsens hair growth in women with PCOS.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.